-
Enhancing Understanding of Quality of Life in Multiple Sclerosis Through Social Listening: Complementing Traditional HRQoL Measures
Sep 9, 2025, 16:22 PM -
The Impact of Generalized Anxiety Disorder on Comorbid Conditions: A Systematic Review
Sep 9, 2025, 16:22 PM -
Danicopan: A Dominant Option for the Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) With Residual Hemolytic Anemia in Spain
Sep 9, 2025, 16:22 PM -
Piloting Structured Expert Elicitation: An Exploratory Case Study of Practical Implementation
Sep 9, 2025, 16:22 PM -
Delayed Impact, Limited Leverage: Revenue Dynamics of Patent-Protected Drugs and the Effectiveness of Price-Volume Agreements in Germany
Sep 9, 2025, 16:22 PM -
Budget Impact Analysis of Introducing Nirsevimab Into the National Immunization Program for Infants in Korea
Sep 9, 2025, 16:22 PM -
Economic Value of Dupilumab in Preventing and Treating Comorbid Asthma in Pediatric Patients With Atopic Dermatitis: A Cost-Offset Model From the Italian Payer Perspective
Sep 9, 2025, 16:22 PM -
US Payer Assessment of the Utility and Impact of Value Dossiers on Decision Making
Sep 9, 2025, 16:22 PM -
The Disease Burden of Respiratory Syncytial Virus Among the Adult Population in Greece
Sep 9, 2025, 16:22 PM -
Patient and Caregiver Recommendations for Person-Centered Oncology Clinical Trial Design: A Qualitative Study
Sep 9, 2025, 16:22 PM -
Comparison EQ-5D-Y-3L Responses Between Child Self-Reports and Caregiver Proxy Reports
Sep 9, 2025, 16:22 PM -
The Association Between Schizophrenia and Cardiovascular Diseases: A Retrospective Cohort Study in German Primary Care
Sep 9, 2025, 16:22 PM -
Epidemiology and Demographic Characteristics of Phenylketonuria in Brazil: A Real-World Data Study (2019-2024)
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) Among High-Risk Adults in Taiwan
Sep 9, 2025, 16:22 PM -
Can We Quantify the Financial Impact of Patient-Reported Outcomes on the Value of Oncology Products?
Sep 9, 2025, 16:22 PM -
A Retrospective Assessment of Drug Eligibility for NICE’s Highly Specialized Technologies Program Using the 2025 Criteria
Sep 9, 2025, 16:22 PM -
Trends and Characteristics of Thrombectomy Use in Acute Ischemic Stroke in Germany (2019-2024): Insights From National Claims Data
Sep 9, 2025, 16:22 PM -
Epidemiological Study of Pulmonary Hypertension in Patients With Interstitial Lung Diseases (PH-ILD) in Greece: A Retrospective Multicenter Study
Sep 9, 2025, 16:22 PM -
A Novel View on the Treatment Costs of Relapsed or Refractory Diffuse Large B-cell Lymphoma From the Brazilian Private Healthcare System Perspective: A First- to Third-Line Analysis
Sep 9, 2025, 16:22 PM -
A Retrieval-Augmented Generation (RAG)-Based Framework to Automate Report Writing for Systematic Literature Reviews (SLRs) in Evidence Synthesis
Sep 9, 2025, 16:22 PM
